Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study is a prospective, multicentre, randomized, open-label, blinded-endpoint clinical
trial to evaluate the efficacy and safety of Yangxinshi tablets in the treatment of patients
with chronic coronary syndrome (CCS).